Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

MOAT vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, MOAT returned +10.3% to XBI's +41.2%, and XBI charges 0.35% to MOAT's 0.46%.

askIQ about this page

askIQ about MOAT and XBI

Net assets on Oct 27, 2026: $11.6bn for VanEck Morningstar Wide Moat ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

At a glance
+10.3%
MOAT total return, 1 year
+41.2%
XBI total return, 1 year
0.46%
MOAT expense ratio
0.35%
XBI expense ratio

Pair scorecard

XBI costs 0.11 points a year less; their one-year returns differ by 30.9 points; MOAT is 1.1 times larger.

MOAT vs XBI: Differences, Returns & Fees
MeasureMOATXBI
Return
Total return, 1 year+10.3%+41.2%
Drawdown
Below its high3.7%, high on Aug 27, 2026
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksMorningstar Wide Moat Focus IndexBiotech
Cost and size
Expense ratio0.46%0.35%
Net assets, as of Oct 27, 2026$11.6bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
Top ten holdings, share of the fund26.5%18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, MOAT and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first MOAT XBI
Only in one fund ↓
Only in MOAT
Danaher Corp 2.85%
Microsoft Corp 2.81%
Estee Lauder Cos Inc 2.78%
Tyler Technologies Inc 2.73%
Broadridge Financial Solutions Inc 2.65%
Brown-Forman Corp 2.57%
Kenvue Inc 2.57%
Ge Healthcare Technologies Inc 2.55%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

MOAT VanEck Morningstar Wide Moat ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks the Morningstar Wide Moat Biotech
Total return, 1 year +10.3% +41.2%
Its benchmark over the same days +13.7% (VOO) not measured
Gap to its benchmark −3.4 pts vs VOO not measured
Expense ratio 0.46% 0.35%
Already in the S&P 500 91.6% 13.2%
Holdings 54 165
Net assets, as of Oct 27, 2026 $11.6bn $10.3bn

MOAT and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

MOAT and XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
MOAT

MOAT tracks the Morningstar Wide Moat. Over the year to Oct 28, 2026 it returned +10.3% with distributions reinvested, against +13.7% for its benchmark, the S&P 500 Index. The prospectus expense ratio is 0.46% a year. By its holdings published by its issuer for Oct 27, 2026, 92% of the fund by weight is stocks the S&P 500 also holds, across 54 positions, with the top ten at 26.5%. It sat 3.7% below its high of Aug 27, 2026 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are MOAT and XBI in the same category?
MOAT is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, MOAT or XBI?
In the year to Oct 28, 2026, with distributions reinvested, MOAT returned +10.3% and XBI +41.2%.
Which is cheaper, MOAT or XBI?
XBI is cheaper, by 0.11 percentage points a year. That is about $11 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do MOAT and XBI overlap with the S&P 500?
By their latest filed holdings, 92% of MOAT and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, MOAT against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/moat-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.